Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2
- PMID: 33135055
- PMCID: PMC7665489
- DOI: 10.1093/glycob/cwaa101
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2
Abstract
The emergence of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created the need for development of new therapeutic strategies. Understanding the mode of viral attachment, entry and replication has become a key aspect of such interventions. The coronavirus surface features a trimeric spike (S) protein that is essential for viral attachment, entry and membrane fusion. The S protein of SARS-CoV-2 binds to human angiotensin converting enzyme 2 (hACE2) for entry. Herein, we describe glycomic and glycoproteomic analysis of hACE2 expressed in HEK293 cells. We observed high glycan occupancy (73.2 to 100%) at all seven possible N-glycosylation sites and surprisingly detected one novel O-glycosylation site. To deduce the detailed structure of glycan epitopes on hACE2 that may be involved in viral binding, we have characterized the terminal sialic acid linkages, the presence of bisecting GlcNAc and the pattern of N-glycan fucosylation. We have conducted extensive manual interpretation of each glycopeptide and glycan spectrum, in addition to using bioinformatics tools to validate the hACE2 glycosylation. Our elucidation of the site-specific glycosylation and its terminal orientations on the hACE2 receptor, along with the modeling of hACE2 glycosylation sites can aid in understanding the intriguing virus-receptor interactions and assist in the development of novel therapeutics to prevent viral entry. The relevance of studying the role of ACE2 is further increased due to some recent reports about the varying ACE2 dependent complications with regard to age, sex, race and pre-existing conditions of COVID-19 patients.
Keywords: ACE2 glycosylation; ACE2 site mapping; COVID-19 receptor; SARS-CoV-2 receptor; hACE2 N-glycosylation.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.Microbiol Spectr. 2021 Oct 31;9(2):e0119921. doi: 10.1128/Spectrum.01199-21. Epub 2021 Sep 8. Microbiol Spectr. 2021. PMID: 34494876 Free PMC article.
-
Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection.J Virol. 2025 May 20;99(5):e0220224. doi: 10.1128/jvi.02202-24. Epub 2025 Mar 28. J Virol. 2025. PMID: 40152594 Free PMC article.
-
Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.Elife. 2020 Oct 26;9:e61552. doi: 10.7554/eLife.61552. Elife. 2020. PMID: 33103998 Free PMC article.
-
The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.Tumour Biol. 2021;43(1):177-196. doi: 10.3233/TUB-200084. Tumour Biol. 2021. PMID: 34420993 Review.
-
Glycosylation of SARS-CoV-2: structural and functional insights.Anal Bioanal Chem. 2021 Dec;413(29):7179-7193. doi: 10.1007/s00216-021-03499-x. Epub 2021 Jul 7. Anal Bioanal Chem. 2021. PMID: 34235568 Free PMC article. Review.
Cited by
-
Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern.Front Cell Infect Microbiol. 2022 Aug 30;12:989534. doi: 10.3389/fcimb.2022.989534. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36111239 Free PMC article.
-
Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction.PLoS One. 2021 Sep 28;16(9):e0257905. doi: 10.1371/journal.pone.0257905. eCollection 2021. PLoS One. 2021. PMID: 34582502 Free PMC article.
-
Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries.Cell Discov. 2021 Jul 27;7(1):57. doi: 10.1038/s41421-021-00295-w. Cell Discov. 2021. PMID: 34315862 Free PMC article.
-
SARS-CoV-2 Omicron Subvariants Do Not Differ Much in Binding Affinity to Human ACE2: A Molecular Dynamics Study.J Phys Chem B. 2024 Apr 11;128(14):3340-3349. doi: 10.1021/acs.jpcb.3c06270. Epub 2024 Apr 2. J Phys Chem B. 2024. PMID: 38564480 Free PMC article.
-
Inhibition of Protein N-Glycosylation Blocks SARS-CoV-2 Infection.mBio. 2021 Feb 22;13(1):e0371821. doi: 10.1128/mbio.03718-21. Epub 2022 Feb 15. mBio. 2021. PMID: 35164559 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous